MedTrace Logo

Study of Sonographic Efficacy of Rituximab in Rheumatoid Arthritis

NCT01765374 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-04-16

No results posted yet for this study

Summary

To detect by sonography relapse of disease activity prior to clinical symptoms in RA patients treated by rituximab.

Conditions

Interventions

DEVICE

ESAOTE MyLab60

US evaluation at different time points

DRUG

Rituximab

Sponsors & Collaborators

  • University Hospital, Rouen

    lead OTHER

Principal Investigators

  • Olivier Vittecoq, MD,PHD · University Hospital, Rouen

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01765374 on ClinicalTrials.gov